ASHFORD CLINICAL PROVIDERS LIMITEDActive

Company number 09052134Private limited companyIncorporated 2014

Key figures

£491,184-16.3%
Net assets 2025/26
+7.7%
Average annual growth 2019/20–2025/26
0200 k400 k600 k2019/202020/212021/222022/232023/242024/252025/26

Like most small UK companies, ASHFORD CLINICAL PROVIDERS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025/26
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
01 m2 m2019/202020/212021/222022/232023/242024/252025/26
Filed accounts2019/20–2025/26
2021/222022/232023/242024/252025/26
Cash at bank and in hand1,174,5731,065,8021,139,6981,146,2751,151,710
Total assets1,641,2561,383,2821,231,6071,462,7501,215,716
Total liabilities1,099,053865,595657,201875,647724,532
Net assets / total equity542,203518,991575,058587,103491,184
Average number of employees10001010

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: ASHFORD CLINICAL PROVIDERS LIMITED

Company

ASHFORD CLINICAL PROVIDERS LIMITED is a private limited company registered with Companies House under company number 09052134. It was incorporated on 22 May 2014. Its status is active. The registered office is in Canterbury (CT1). Its nature of business (SIC 2007) is general medical practice activities (86210).

Accounts

The latest accounts in the database are for 2025/26 (period ending 31 May 2026); the company files small company accounts (filleted). Net assets were £491,184, down 16.3% on the previous year. Cash at bank and in hand was £1,151,710. Total assets were £1,215,716 and total liabilities £724,532. The company had an average of 10 employees. Figures are available for 7 financial years (2019/20–2025/26).

Control and charges

The company has 10 current directors.

Filing deadlines

The next accounts are due by 28 Feb 2027. The next confirmation statement is due by 5 Jun 2027.